Pulmozyme May Extend Lives of People Without Cystic Fibrosis
Pulmozyme might be able to extend the lives of people who don’t have CF according to a recent article in […]
New Guidelines for Cystic Fibrosis Diagnosis
New Guidelines for Cystic Fibrosis Diagnosis A group of 32 scientists from nine countries have updated the guidelines for Cystic […]
Radio Interview: CRISPR Gene Editing (relevant to Cystic Fibrosis genetics)
“There has never been a more powerful biological tool or one with more potential to both improve the world and […]
Cystic Fibrosis Lung Microbiome: Diversity and Lung Function
The article, The Lung Microbiome and Airway Disease, published September 2016 in the Annals of the American Thoracic Society, describes […]
CFTR Function and Cigarette Smoke
Scientists are looking at how the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) potentiator, Ivacaftor, might be used in COPD, specifically […]
Lumacaftor/Ivacaftor longer trial on Heterozygous F508del Cystic Fibrosis Patients
At the end of November, the results of a clinical trial of Lumacaftor/Ivacaftor, also known as Orkambi, in CF patients […]
The Lung Microbiome and Dysbiosis
The “microbiome” is a hot topic in respiratory medicine, with researchers from diverse fields such as chronic obstructive pulmonary disease, […]
Redesigning Prescription Medication Inserts
Six everyday items were re-imagined by designers in this week’s New York Times Magazine. A data visualization firm, Periscopic, and […]
North American Cystic Fibrosis Conference 2016
The 30th annual North American Cystic Fibrosis Conference took place in October 2016 in Orlando, FL and offered more more than […]
Bluetooth-enabled tech shows promise for adherence in Cystic Fibrosis treatment
A device that monitors inhaled antibiotic use in Cystic Fibrosis treatment, and transmits the information to doctors via Bluetooth technology […]